Fulranumab

DB12102InvestigationalProtein Based Therapies

Fulranumab has been used in trials studying the treatment of Pain, Cystitis, Neuralgia, Joint Pain, and Arthralgia, among others.

Mechanism: Pharmacologically active on Beta-nerve growth factor
Curator reviewed
Code names: JNJ-42160443

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

8Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fulranumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.